Search results
Author(s):
Nicolas M Van Mieghem
,
Roxana Mehran
,
Holger Thiele
,
et al
Start date:
Mar 17, 2023
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Jun 10, 2020
The programme aims to educate interventionalists and allied healthcare professionals on the practical implications of the latest clinical data, device selection and procedural strategies impacting optimum patient care. To further illustrate this, the event will feature a number of practical demonstrations in the form of live cases broadcast from cardiovascular centres of excellence globally,…
View more
Author(s):
Jan Balzer
,
Tobias Zeus
,
Verena Veulemans
,
et al
Added:
3 years ago
Percutaneous catheter-based structural heart disease procedures are a rapidly growing area of interventional cardiology, and represent a valuable option for cardiac patients with comorbidities who are ineligible for conventional surgery as well as demonstrating excellent outcomes.1,2 Catheter-based interventions include transcatheter aortic valve implantation (TAVI),3 percutaneous mitral valve …
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Start date:
Apr 03, 2020
Prof Nicolas van Mieghem & Dr Joost Daemen (Erasmus MC, Rotterdam, NL) review and discuss the results of the late-breaking trials of ACC 2020. Streaming live on Radcliffe Cardiology.
View more
Author(s):
Nicolas M Van Mieghem
Start date:
Dec 08, 2016
An interactive live case collaboration between the Thoraxcenter, Erasmus MC and Interventional Cardiology Review.
View more
Author(s):
Kendra J Grubb
Added:
5 months ago
TCT 23 - We are joined by Dr Kendra Grubb (Emory School of Medicine, Atlanta, GA, US) for a concise and insightful summary of the late-breaking trials that are expected to have an impact on interventional science concerning structural heart disease and clinical practice.
Trials covered in detail include:
PARTNER 3 & EVOLUT Low-Risk
ALIGN-AR
TENDYNE
APOLLO
TRILUMINATE
Recorded remotely…
View more
Author(s):
Darren Mylotte
,
Ruben LJ Osnabrugge
,
Giuseppe Martucci
,
et al
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) has emerged as a safe and efficacious treatment in patients with symptomatic severe aortic stenosis (AS) at high- or excessive-risk for surgical aortic valve replacement.1,2 More recently, TAVI technology has been extended to treating high-risk patients with failing aortic or mitral surgical bioprosthetic valves, bicuspid aortic stenosis, pure aortic…
View more
ACC 2023: Late-Breaking Science Video Collection
Author(s):
Enoch Akowuah
,
Annapoorna Kini
,
Atul Verma
,
et al
Added:
1 year ago
Video Series
Transcatheter Interventions Online 2023 - On Demand
Video Series
Author(s):
David Hildick-Smith
,
Ajay J Kirtane
,
Nicolas M Van Mieghem
,
et al
Start date:
Mar 16, 2023